ES2139574T3 - Nuevos gases propulsores y su uso en preparaciones medicas. - Google Patents

Nuevos gases propulsores y su uso en preparaciones medicas.

Info

Publication number
ES2139574T3
ES2139574T3 ES91903267T ES91903267T ES2139574T3 ES 2139574 T3 ES2139574 T3 ES 2139574T3 ES 91903267 T ES91903267 T ES 91903267T ES 91903267 T ES91903267 T ES 91903267T ES 2139574 T3 ES2139574 T3 ES 2139574T3
Authority
ES
Spain
Prior art keywords
gases
medical preparations
propeller
new propeller
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91903267T
Other languages
English (en)
Inventor
Hans-Hermann Weil
Ottfried Daab
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Boehringer Ingelheim Pharmaceuticals Inc
Original Assignee
Boehringer Ingelheim Pharma GmbH and Co KG
Boehringer Ingelheim Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6399399&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2139574(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma GmbH and Co KG, Boehringer Ingelheim Pharmaceuticals Inc filed Critical Boehringer Ingelheim Pharma GmbH and Co KG
Application granted granted Critical
Publication of ES2139574T3 publication Critical patent/ES2139574T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K3/00—Materials not provided for elsewhere
    • C09K3/30—Materials not provided for elsewhere for aerosols

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

LOS NUEVOS Y VENTAJOSOS GASES PROPULSORES CONTIENEN, ADEMAS DE 1,1,1,2,3,3,3 MAS COMPONENTES DE GASES PROPULSORES Y PUEDEN ENCONTRAR UTILIZACION EN PREPARADOS MEDICOS.
ES91903267T 1990-02-03 1991-01-31 Nuevos gases propulsores y su uso en preparaciones medicas. Expired - Lifetime ES2139574T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4003270A DE4003270A1 (de) 1990-02-03 1990-02-03 Neue treibgase und ihre verwendung in arzneimittelzubereitungen

Publications (1)

Publication Number Publication Date
ES2139574T3 true ES2139574T3 (es) 2000-02-16

Family

ID=6399399

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91903267T Expired - Lifetime ES2139574T3 (es) 1990-02-03 1991-01-31 Nuevos gases propulsores y su uso en preparaciones medicas.

Country Status (25)

Country Link
US (7) US6419899B1 (es)
EP (1) EP0513099B1 (es)
JP (1) JP3497162B2 (es)
KR (1) KR920703034A (es)
AT (1) ATE185587T1 (es)
AU (1) AU656129B2 (es)
CA (1) CA2075060C (es)
CZ (1) CZ285209B6 (es)
DE (2) DE4003270A1 (es)
DK (1) DK0513099T3 (es)
ES (1) ES2139574T3 (es)
FI (1) FI103348B (es)
GR (1) GR3032176T3 (es)
HR (1) HRP940737B1 (es)
HU (1) HU218664B (es)
IL (1) IL97024A0 (es)
NO (1) NO302420B1 (es)
NZ (1) NZ236974A (es)
PT (1) PT96635B (es)
RU (1) RU2118170C1 (es)
SI (1) SI9110155B (es)
SK (1) SK281440B6 (es)
WO (1) WO1991011496A1 (es)
YU (1) YU48509B (es)
ZA (1) ZA91756B (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4003270A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
MX9203481A (es) 1990-10-18 1992-07-01 Minnesota Mining & Mfg Formulaciones.
CA2094266C (en) * 1990-10-18 1999-06-01 Robert K. Schultz Aerosol formulations of beclomethasone-17,21-dipropionate
CA2111002C (en) * 1991-06-10 2000-08-22 Julianne Fassberg Non-chlorofluorocarbon aerosol formulations
US5221492A (en) * 1991-08-23 1993-06-22 E. I. Du Pont De Nemours And Company Azeotropic mixture of perfluoropropane and dimethyl ether
GB9118830D0 (en) * 1991-09-03 1991-10-16 Minnesota Mining & Mfg Medical aerosol formulations
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5916540A (en) * 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
DK0616525T3 (da) * 1991-12-12 1996-01-08 Glaxo Group Ltd Medikamenter
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
EP0616524B1 (en) 1991-12-12 1998-10-07 Glaxo Group Limited Medicaments
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
ATE204743T1 (de) 1991-12-18 2001-09-15 Minnesota Mining & Mfg Aerosolzusammensetzungen für arzneimittelsuspensionen
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
US20030103907A1 (en) * 1991-12-18 2003-06-05 Schultz Robert K. Suspension aerosol formulations
AU3936293A (en) * 1992-03-26 1993-10-21 Great Lakes Chemical Corporation Azeotrope-like compositions of 1,1,1,2,3,3,3-heptafluoropropane and 1,1-difluoroethane
RO117414B1 (ro) * 1992-12-09 2002-03-29 Jager Paul D Waterbury Compozitie farmaceutica de aerosol in solutie
NZ276637A (en) * 1993-12-20 1997-07-27 Minnesota Mining & Mfg Aerosol containing flunisolide, ethanol, and tetrafluoroethane and/or heptafluoropropane propellant
KR100428914B1 (ko) 1994-12-22 2004-06-16 아스트라제네카 악티에볼라그 에어로졸약물제제
US6135628A (en) * 1995-10-13 2000-10-24 Boehringer Ingelheim Pharmceuticals, Inc. Method and apparatus for homogenizing aerosol formulations
US6054488A (en) * 1996-06-11 2000-04-25 3M Innovative Properties Company Medicinal aerosol formulations of formoterol
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
DE19652790A1 (de) * 1996-12-18 1998-06-25 Hermes Fabrik Pharm Praeparate Pharmazeutische Zubereitungen
US6235265B1 (en) * 1998-10-28 2001-05-22 Alliedsignal Inc. Evaporative coolant for topical anesthesia comprising hydrofluorocarbons and/or hydrochlorofluorocarbons
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
DE10050994A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
US6706726B2 (en) 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
US7754242B2 (en) * 2002-03-20 2010-07-13 Alkermes, Inc. Inhalable sustained therapeutic formulations
US7582284B2 (en) 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
US7273603B2 (en) 2003-07-11 2007-09-25 Boehringer Ingelheim International Gmbh HFC solution formulations containing an anticholinergic
WO2005041931A2 (en) * 2003-10-20 2005-05-12 Schering Corporation Pharmaceutical aerosol compositions
CA2571519C (en) * 2004-07-02 2013-05-14 Boehringer Ingelheim International Gmbh Aerosol suspension formulations containing tg 227 ea or tg 134 a as a propellant
CA2607391A1 (en) * 2005-04-23 2006-11-02 Boehringer Ingelheim International Gmbh Combination of medicaments to be inhaled, containing a betamimetic agent and a steroid in addition to an anticholinergic agent
DE102006017320A1 (de) * 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
ES2538082T3 (es) 2007-02-11 2015-06-17 Map Pharmaceuticals Inc Método de administración terapéutica de DHE para permitir el rápido alivio de migraña mientras que se minimiza el perfil de efectos secundarios
EP2282418A3 (en) 2009-06-23 2011-03-09 Alcatel Lucent A station comprising at least two transmit antennas, and a method of transmitting therefrom
EP2935280A4 (en) 2012-12-21 2016-05-25 Map Pharmaceuticals Inc 8'-HYDROXY-DIHYDROERGOTAMINE COMPOUNDS AND COMPOSITIONS

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2490764A (en) * 1945-07-04 1949-12-13 Kinetic Chemicals Inc Fluorinated organic compounds
BE555319A (es) * 1956-03-21 1900-01-01
BE556587A (es) 1957-01-31 1957-04-11
GB902590A (en) 1960-03-22 1962-08-01 Allied Chem Production of heptafluoropropane
US3095355A (en) * 1961-10-12 1963-06-25 Revlon Aerosol composition
BE629985A (es) * 1962-11-29
DE1542076A1 (de) * 1966-04-21 1970-03-26 Colgate Palmolive Co Aerosol-Treibmittel
US3369913A (en) * 1967-03-20 1968-02-20 Union Carbide Corp Self-propelling food mixture
DE1719443B2 (de) 1967-10-07 1973-04-05 Suspensions-aerosole und verfahren zu ihrer herstellung
US4044126A (en) * 1972-04-20 1977-08-23 Allen & Hanburys Limited Steroidal aerosol compositions and process for the preparation thereof
FI770215A7 (es) 1976-01-30 1977-07-31 Fisons Ltd
NL7708731A (nl) * 1976-08-13 1978-02-15 Montedison Spa Werkwijze voor de bereiding van nieuwe drijf- middelsamenstellingen voor aerosolen.
US4174795A (en) * 1977-02-14 1979-11-20 Bohm Leslie E Pannier mounting arrangement for cycles
GB2001334B (en) 1977-07-19 1982-03-03 Fisons Ltd Pressurised aerosol formulation
CA1136547A (en) 1979-03-08 1982-11-30 Song-Ling Lin Aerosol anesthetic compositions
JPS55131096A (en) 1979-03-30 1980-10-11 Daikin Ind Ltd Working fluid for rankine cycle
US4352789A (en) 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
US4352798A (en) * 1980-07-16 1982-10-05 Glaxo Group Limited 11 α-Amino-androstanes
GB8432063D0 (en) * 1984-12-19 1985-01-30 Riker Laboratories Inc Physically modified steroids
GB8501015D0 (en) 1985-01-16 1985-02-20 Riker Laboratories Inc Drug
US4778674A (en) * 1986-05-28 1988-10-18 Richardson-Vicks Inc. Dry aerosol foam
DE3735467A1 (de) 1987-10-20 1989-05-03 Bayer Ag Verfahren zur herstellung von fluorierten c(pfeil abwaerts)4(pfeil abwaerts)- bis c(pfeil abwaerts)6(pfeil abwaerts)-kohlenwasserstoffen und neue cyclische fluorierte kohlenwasserstoffe, sowie die verwendung von fluorierten c(pfeil abwaerts)4(pfeil abwaerts)- bis c(pfeil abwaerts)6(pfeil abwaerts)-kohlenwasserstoffen als treibgas und arbeitsfluessigkeit fuer waermepumpensysteme
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE3903336A1 (de) 1989-02-04 1990-08-09 Bayer Ag Verwendung von c(pfeil abwaerts)3(pfeil abwaerts)- bis c(pfeil abwaerts)5(pfeil abwaerts)-polyfluoralkanen als treibgase
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
JP2642738B2 (ja) 1989-04-13 1997-08-20 ライオン株式会社 人体塗布用エアゾール製品
DE4003270A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
IL97065A (en) 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
DE4003272A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
US5118494A (en) * 1990-03-23 1992-06-02 Minnesota Mining And Manufacturing Company Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
US5182097A (en) * 1991-02-14 1993-01-26 Virginia Commonwealth University Formulations for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
EP0504112A3 (en) 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
CA2111002C (en) 1991-06-10 2000-08-22 Julianne Fassberg Non-chlorofluorocarbon aerosol formulations
IL102130A0 (en) 1991-06-10 1993-01-14 Schering Corp Non-chlorofluorocarbon aerosol formulations
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
ATE137666T1 (de) 1991-12-31 1996-05-15 Hoechst Ag Medizinische aerosolformulierung
GB9425160D0 (en) * 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
KR100428914B1 (ko) 1994-12-22 2004-06-16 아스트라제네카 악티에볼라그 에어로졸약물제제
ATE258813T1 (de) * 1995-04-14 2004-02-15 Smithkline Beecham Corp Vorrichtung zur dosierten inhalierung von beclomethason-diproprionat
PT1014943E (pt) 1997-02-05 2002-11-29 Jago Res Ag Formulacoes medicinais de aerossois
US5891420A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe triancinolone acetonide aerosol formulations for oral inhalation

Also Published As

Publication number Publication date
FI103348B1 (fi) 1999-06-15
HRP940737A2 (en) 1997-06-30
ZA91756B (en) 1992-10-28
JPH05504350A (ja) 1993-07-08
CZ285209B6 (cs) 1999-06-16
EP0513099B1 (de) 1999-10-13
HRP940737B1 (en) 2000-10-31
FI923491A0 (fi) 1992-08-03
RU2118170C1 (ru) 1998-08-27
DK0513099T3 (da) 2000-04-10
US20020071812A1 (en) 2002-06-13
GR3032176T3 (en) 2000-04-27
CA2075060A1 (en) 1991-08-04
HU9202508D0 (en) 1992-10-28
FI103348B (fi) 1999-06-15
US7160538B2 (en) 2007-01-09
PT96635A (pt) 1991-10-31
PT96635B (pt) 1998-07-31
NO923040D0 (no) 1992-07-31
YU15591A (sh) 1994-01-20
YU48509B (sh) 1998-09-18
US6419899B1 (en) 2002-07-16
US20040028618A1 (en) 2004-02-12
AU7211691A (en) 1991-08-21
US20090104127A1 (en) 2009-04-23
US20110014134A1 (en) 2011-01-20
AU656129B2 (en) 1995-01-27
SI9110155B (sl) 1999-06-30
WO1991011496A1 (de) 1991-08-08
NO302420B1 (no) 1998-03-02
NZ236974A (en) 1993-07-27
SK281440B6 (sk) 2001-03-12
US20050031548A1 (en) 2005-02-10
FI923491L (fi) 1992-08-03
JP3497162B2 (ja) 2004-02-16
US20070065370A1 (en) 2007-03-22
CS9100265A2 (en) 1991-09-15
HUT62455A (en) 1993-05-28
ATE185587T1 (de) 1999-10-15
EP0513099A1 (de) 1992-11-19
DE59109161D1 (de) 1999-11-18
NO923040L (no) 1992-07-31
CA2075060C (en) 2001-01-02
HK1010737A1 (en) 1999-06-25
HU218664B (hu) 2000-10-28
DE4003270A1 (de) 1991-08-08
KR920703034A (ko) 1992-12-17
SI9110155A (sl) 1998-04-30
IL97024A0 (en) 1992-03-29

Similar Documents

Publication Publication Date Title
ES2139574T3 (es) Nuevos gases propulsores y su uso en preparaciones medicas.
DE3484997D1 (de) Zellstimulierendes mittel.
ES1005721Y (es) Sillo plagable con dos o mas posiciones de empleo
SE8501709D0 (sv) Improvements in or relating to intrleukin therapy
MX9405383A (es) Imidazo(4,5-c) piridin-4-aminas.
DK0812198T3 (da) Stabilisering af prostaglandinpræparater
ES2025198B3 (es) Butaca plegable con respaldo y reposapies regulable.
IT1209603B (it) Derivati 2,6-disostituiti di naftalene, procedimento per prepararli e loro uso nel campo farmaceutico e cosmetico.
ES2186783T3 (es) Derivados de la dolastatina, su preparacion y uso.
NO782887L (no) Kombinert ryggsekkmeis og stol.
GR890100008A (el) Παράγωγα ισοκινολίνης, παρασκευή τους και χρήση τους.
ES2151607T3 (es) Factor 12 de crecimiento y de diferenciacion.
MX9702666A (es) Nuevos peptidos con efectos inmunoreguladores.
MX9302927A (es) Nuevos peptidos, la preparacion y utilizacion de los mimos.
ATE58639T1 (de) Appetit mildernde und gegen gastritis wirksame zusammensetzung.
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
FI852730A0 (fi) (pyrrol-1-yl) -fenyl-dihydropyridazinoner, deras framstaellning och anvaendning.
IT8025482A0 (it) Membrana modificata morfologicamente ed uso della stessa in procedimenti di elettrolisi.
IT9019565A0 (it) Agenti addensanti,loro preparazione ed uso
ZA891242B (en) 24r-scymnol,and preparation and use thereof
BR9106372A (pt) Derivados 1,5-benzotiazepinona,suas preparacoes e uso farmaceutico
ES2158441T3 (es) Arilheterociclos con actividad herbicida.
GR3005231T3 (es)
IT1248838B (it) Soluzioni tampone contenenti collagenasi, loro preparazione ed uso perla diluizione di sieri umani
SE7700781L (sv) 1,3-dihydro-1'-dimetylfosfinylalkyl-3-fenylspiro(isobensofuran)er

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 513099

Country of ref document: ES